Launch event: European Drug Report 2022
What do the latest data tell us about trends in drug use and the market? What hazardous new drugs are emerging? What substances are posing the greatest health threats? Find out more when the EU drugs agency (EMCDDA) launches its European Drug Report 2022: Trends and Developments in a live online press conference on 14 June.
Event details
Date: 14 June 2022 at 10.00 (Lisbon), 11.00 CET (Brussels)
Press conference (online):
- Ylva Johansson, European Commissioner for Home Affairs
- Franz Pietsch, Chair of the EMCDDA Management Board (Austria)
- Alexis Goosdeel, EMCDDA Director
Embargoed copies and interviews: press@emcdda.europa.eu
Languages: The press conference will be in English, with simultaneous interpretation available (ES, DE, FR, PT).
Related resources
- European Drug Report 2022: Trends and developments (publication)
- New psychoactive substances: 25 years of early warning and response in Europe — an update from the EU Early Warning System (publication)
- Highlights from the report: drug supply and use bounce back after COVID-19 disruption (news release)
- Statistical Bulletin 2022
Press material
Video
News
- Highlights from the report: drug supply and use bounce back after COVID-19 disruption (news release)
- 25 years of monitoring and responding to new drugs in Europe — update published today (news release)
- Coming soon: European Drug Report 2022 to be released on 14 June (in 24 languages)
Speeches
- Speech by Commissioner Ylva Johansson (video)
- Transcript of speech by Commissioner Ylva Johansson (transcript)
- Recording of speech by the Chair of EMCDDA Management Board Franz Pietsch (video)
- Transcript of speech by the Chair of EMCDDA Management Board Franz Pietsch (transcript)
- Trasnscript of speech by EMCDDA Director, Alexis Goosdeel (transcript)